In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal ...

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...

Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in lab studies, though long-term safety in humans remains unknown.

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut hole.” ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.

By Deena Beasley and Nancy Lapid May 14 (Reuters) - U.S. cancer centers are scrambling to enroll patients in an early access ...